Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 is a synthesized conjugate compound known as an E3 ligase ligand-linker. It incorporates a cereblon ligand based on Thalidomide and a 3-unit PEG linker. This compound is specifically designed for use in PROTAC technology applications.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 is a synthesized conjugate compound known as an E3 ligase ligand-linker. It incorporates a cereblon ligand based on Thalidomide and a 3-unit PEG linker. This compound is specifically designed for use in PROTAC technology applications. |
Synonyms | E3 Ligase Ligand-Linker Conjugates 23 TFA, Cereblon Ligand-Linker Conjugates 12 TFA |
Molecular Weight | 648.58 |
Formula | C27H35F3N4O11 |
CAS No. | T17917 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 T17917 Others E3 Ligase Ligand-Linker Conjugates 23 TFA Cereblon Ligand-Linker Conjugates 12 TFA Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 Thalidomide-O-amido-PEG-1-(C1-PEG)2-C2-NH2 ThalidomideOamidoPEG1(C1PEG)2C2NH2 Thalidomide O amido PEG1 (C1 PEG)2 C2 NH2 inhibitor inhibit